Endoscopic treatment of gastroesophageal reflux disease

Kristin Hummel; William Richards

doi:10.1016/j.suc.2015.02.016

Endoscopic treatment of gastroesophageal reflux disease

Surg Clin North Am. 2015 Jun;95(3):653-67. doi: 10.1016/j.suc.2015.02.016.

Authors

Kristin Hummel¹, William Richards²

Affiliations

¹ Department of Surgery, University of South Alabama College of Medicine, Mastin Building, 2451 Fillingim Street, Mobile, AL 36617, USA.
² Department of Surgery, University of South Alabama College of Medicine, Mastin Building, 2451 Fillingim Street, Mobile, AL 36617, USA. Electronic address: brichards@health.southalabama.edu.

PMID: 25965137
DOI: 10.1016/j.suc.2015.02.016

Abstract

Multiple new endoluminal devices and therapies have been devised to create a more effective antireflux barrier in patients with gastroesophageal reflux disease (GERD). Most of these therapies have been abandoned, because they were ineffective and/or had significant adverse effects. However, there are currently two therapies (Stretta, EsophyX) that have US Food and Drug Administration approval and continue to be used in select patients with GERD. The clinical management of GERD, disease complications, endoluminal techniques, evidence for efficacy, and controversies concerning endoluminal therapy for GERD are reviewed and discussed.

Keywords: Endoluminal devices; EsophyX; Gastroesophageal reflux disease; Stretta.

Published by Elsevier Inc.

Publication types

Review

MeSH terms

Angioplasty / methods
Catheter Ablation / methods*
Esophagoscopy / methods*
Fundoplication / methods*
Gastroesophageal Reflux / surgery*
Humans
Treatment Outcome